Search

everythinglearnresearchcommunity

for

Search:↓

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

High-content screening is useful for finding new treatments for rare diseases and has led to FDA-approved drugs.

3D-printed mesoporous scaffolds show promise for personalized drug delivery with controlled release.

Male faces age with more wrinkles and hair loss, influenced by both body changes and environmental factors.

Researchers created a mouse model for Cushing's syndrome to study glucocorticoid excess and potential treatments.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

Mobile phone radiation may cause DNA damage in human ear hair follicle cells.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.

Obesity is linked to various skin disorders, which can help with early diagnosis and prevention of long-term health issues.

Dermatologists play a key role in identifying and documenting signs of abuse and injury for forensic investigations.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

Created microspheres show potential for safe and effective use in prostate artery embolization.

Aging in men is influenced by genetics and lifestyle, leading to muscle loss, bone issues, and skin damage.

Transfollicular drug delivery is promising but needs more research to improve and understand it better.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Sheep wool follicles absorb different amino acids at various rates and locations, which could affect wool growth based on diet and genetics.

Trichoscopy helps better understand and manage alopecia areata, improving patient outcomes.

Finasteride helps reduce heart enlargement in heart failure patients.

No link found between Coxsackie viruses and pemphigus.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Machine learning can accurately diagnose PCOS non-invasively using clinical and ultrasound features.

Long-COVID causes more health issues after COVID-19, varying by age, sex, and infection wave.

Cepharanthine may help treat lung fibrosis by affecting certain immune cells.

Mesenchymal stem cells show promise in treating COVID-19 by reducing inflammation and aiding recovery, but more research is needed.

The document concludes that various hair and scalp disorders in children have specific treatments and proper diagnosis is essential.